APPLICATION
NDA050336
TYPE
NDA
ORIGINAL APPROVAL
1969-05-27
LATEST ACTION
2000-03-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
TAODiscontinued
TROLEANDOMYCIN EQ 250MG BASE · CAPSULE · ORAL
Approval history
2000-03-06Manufacturing (CMC) · Supplement 31AP
1984-03-21Manufacturing (CMC) · Supplement 3AP
1984-03-15Manufacturing (CMC) · Supplement 2AP
1983-02-01Labeling · Supplement 1AP
1978-04-21Manufacturing (CMC) · Supplement 30AP
1977-11-01Labeling · Supplement 29AP
1977-09-14Manufacturing (CMC) · Supplement 28AP
1977-06-01Labeling · Supplement 27AP
1977-03-24Labeling · Supplement 26AP
1976-09-23Labeling · Supplement 25AP
1976-06-02Manufacturing (CMC) · Supplement 24AP
1976-03-05Manufacturing (CMC) · Supplement 23AP
1976-03-01Labeling · Supplement 21AP
1976-03-01Labeling · Supplement 22AP
1975-05-06Labeling · Supplement 20AP
1975-04-09Labeling · Supplement 19AP
1975-03-03Manufacturing (CMC) · Supplement 18AP
1975-02-28Labeling · Supplement 17AP
1974-12-02Labeling · Supplement 16AP
1974-10-11Labeling · Supplement 15AP
1973-06-12Labeling · Supplement 14AP
1972-08-08Labeling · Supplement 13AP
1972-08-08Labeling · Supplement 12AP
1972-05-16Manufacturing (CMC) · Supplement 11AP
1972-03-13Labeling · Supplement 10AP
1971-05-28Manufacturing (CMC) · Supplement 9AP
1971-02-19Labeling · Supplement 8AP
1970-10-19Manufacturing (CMC) · Supplement 7AP
1970-02-25Labeling · Supplement 6AP
1970-02-05Labeling · Supplement 5AP
1969-12-01Labeling · Supplement 4AP
1969-05-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.